Everything that comes from ATI consortia etc
Due: November 20, 2025 The purpose of this RPP is to support the advanced development, clinical evaluation, and FDA clearance of mNGS-based diagnostic assays for viral and bacterial pathogen detection. BARDA seeks highly flexible, rapidly Read More
Anticipated Release Date: TBD This Statement of Objectives (SOO) solicits proposals for the development of an agent-based synthetic population and infrastructure that provides scalable, adaptable frameworks for modeling and understanding dynamic, interdependent systems across a Read More
Anticipated Release Date: TBD Unmanned Aerial Vehicles (UAVs) have proven to be a force multiplier and revolutionary tactical asset in the Russia-Ukraine war. In addition to conventional munitions, military and civilian UAVs can be equipped Read More
Anticipated Release Date: Q4 2027 This opportunity requires membership in the Medical CBRN Defense Consortium (MCDC). This Consortium releases numerous opportunities throughout the year, so even if this one may not be right for you, we Read More
Due: December 11, 2025 The United States Government (USG) has a requirement to expand domestic commercial biopharmaceutical manufacturing capabilities. To meet this need, the USG is initiating an effort to onshore the manufacturing of novel Read More
Due: December 1, 2025 The U.S. Department of Energy (DOE), through its Office of Cybersecurity, Energy Security, and Emergency Response (CESER), is issuing the Securing ENergy Technology ResiliencY (SENTRY) Opportunity Announcement to solicit innovative proposals Read More
Due: October 8, 2025 The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) focused on surveying current industry capabilities in the engineering, testing, and manufacturing of solutions capable of neutralizing a Read More
Due: September 2, 2025 Preventative treatments and vaccines offer proactive solutions to biological threats: however, many of the current countermeasures are decades old. These prophylactic platforms have stagnated through single threat targeting which is potentiated Read More
Due: September 2, 2025 The Joint Science and Technology Office (JSTO) within the Defense Threat Reduction Agency (DTRA) supports the warfighter by developing medical countermeasures against a wide range of threats, including marine toxins. Exposure Read More
Due: August 4, 2025 The DxR2 program will solicit new point of care/remote-use products with domestic manufacturing capabilities which address test development for Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) biothreats to include glanders, botulism, Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.